Bajaj HealthCare
add_icon

Bajaj HealthCare

336.45
+9.00
(2.75%)
Market Cap
1,132.58 Cr
PE Ratio
62.66
Volume
3,43,552.00
Day High - Low
343.05 - 325.00
52W High-Low
536.00 - 272.35
ann
Q1 Quarterly Results are out. Check out the updated financials1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
1,132.58 Cr
EPS
4.98
PE Ratio
62.66
PB Ratio
2.07
Book Value
158.34
EBITDA
66.03
Dividend Yield
0.46 %
Industry
Healthcare
Return on Equity
9.21
Debt to Equity
0.75
Forecast For
Actual

Company News

View All News
Caret
neutral
Bajaj Healthcare's Nomination & Remuneration Committee approved the grant of 275 ESOPs at ₹5 per option under its 2024 plan.
positive
Bajaj Healthcare reported a net profit of ₹1,369.80 lakh for Q1FY27, reversing from a loss in the prior quarter. Revenue from operations increased to ₹16,563.17 lakh.
neutral
Bajaj Healthcare to Host Q1 Earnings Call on July 21Jul 16, 2026
Bajaj Healthcare has scheduled its Q1 earnings call for July 21 at 4 PM, offering investors and analysts an opportunity to review the company's quarterly performance.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,990.50
#1 4,77,587.63
41.71
#1 61,673.90
12.69
#1 11,565
25.80
66.37
8,056.00
2,13,861.49
81.06
11,067.00
13.95
2,568
13.44
82.30
5,122.80
1,94,854.84
86.65
13,886.20
20.34
2,138
3.28
64.10
1,473.20
1,19,011.77
35.29
29,044.60
2.24
3,870
-39.18
61.43
1,126.80
1,13,382.45
21.72
27,657.90
17.64
5,026
7.82
53.10
2,415.00
1,10,421.66
#1 20.65
29,038.90
#1 26.75
5,356
87.72
49.50
2,469.60
1,01,993.49
51.48
14,636.40
14.85
1,938
29.13
44.89
1,816.20
98,048.75
88.28
6,867.80
22.01
890
#1 123.93
81.68
1,148.10
95,828.36
30.00
35,058.60
3.90
4,158
-69.10
28.48
1,580.20
90,921.21
26.12
33,384.70
3.21
3,376
1.99
57.35
Growth Rate
Revenue Growth
8.72 %
Net Income Growth
-45.50 %
Cash Flow Change
-76.57 %
ROE
-278.83 %
ROCE
268.16 %
EBITDA Margin (Avg.)
-41.06 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
Revenue
218
223
233
329
371
417
664
681
647
482
562
611
635
Expenses
190
193
200
288
328
362
521
561
534
397
460
545
558
EBITDA
29
30
33
41
44
55
143
120
113
85
102
66
78
Operating Profit %
13 %
13 %
13 %
12 %
12 %
12 %
21 %
17 %
17 %
16 %
15 %
11 %
11 %
Depreciation
9
9
11
11
11
12
16
18
17
28
28
28
29
Interest
8
8
8
8
8
6
8
13
18
30
28
22
23
Profit Before Tax
12
14
14
23
24
36
119
90
78
-17
46
23
25
Tax
5
5
6
8
8
11
36
18
15
-2
3
0
0
Net Profit
8
8
8
15
16
25
83
71
64
-14
43
23
18
EPS in ₹
11.13
12.15
11.37
22.01
11.82
18.29
30.11
25.87
15.59
-30.36
13.29
4.98
5.40

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
189
209
219
268
283
343
526
721
898
765
833
923
Fixed Assets
109
130
128
127
156
162
208
270
366
253
238
256
Current Assets
79
78
91
140
124
168
258
398
500
405
485
569
Capital Work in Progress
1
2
0
2
1
5
57
52
22
7
3
8
Investments
0
0
0
0
0
5
0
0
0
0
0
216
Other Assets
79
78
91
140
126
170
261
399
510
506
591
70
Total Equity & Liabilities
189
209
219
268
283
343
526
721
898
765
833
923
Current Liabilities
85
88
93
131
111
138
183
322
434
402
272
333
Non Current Liabilities
22
32
28
23
19
27
85
71
96
85
95
58
Total Equity
82
89
99
114
153
178
258
329
368
278
466
533
Reserve & Surplus
78
82
92
107
146
164
245
315
354
265
433
516
Share Capital
4
7
7
7
7
14
14
14
14
14
16
17

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-0
1
7
-0
-4
10
-12
16
-16
0
Investing Activities
-17
-31
-8
-12
-13
-28
-109
-75
-93
-11
-15
Operating Activities
28
25
22
17
25
21
44
1
-22
92
22
Financing Activities
-11
5
-13
3
-13
3
76
62
131
-97
-6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.30 %
67.30 %
67.42 %
67.49 %
67.49 %
67.69 %
67.73 %
67.73 %
67.73 %
59.19 %
59.19 %
59.19 %
59.19 %
59.19 %
59.19 %
58.29 %
58.59 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.66 %
0.74 %
0.53 %
0.01 %
1.07 %
1.01 %
1.05 %
1.09 %
1.12 %
1.18 %
1.98 %
2.19 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.34 %
0.34 %
0.34 %
0.44 %
0.48 %
0.44 %
0.00 %
1.97 %
2.36 %
2.52 %
3.16 %
3.00 %
2.96 %
2.91 %
1.92 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.79 %
12.67 %
13.95 %
13.95 %
14.85 %
16.53 %
16.71 %
16.50 %
16.67 %
16.45 %
16.80 %
18.44 %
19.45 %
19.91 %
20.17 %
25.52 %
26.94 %
26.72 %
26.63 %
26.24 %
26.62 %
28.49 %
29.81 %
Others
22.94 %
20.06 %
18.79 %
18.79 %
17.89 %
16.21 %
15.99 %
16.21 %
15.57 %
15.73 %
15.37 %
12.78 %
11.61 %
11.39 %
12.09 %
12.26 %
10.50 %
10.52 %
9.93 %
10.45 %
10.05 %
8.33 %
7.48 %
No of Share Holders
7,236
13,283
26,707
31,462
32,309
30,723
30,909
29,769
26,930
26,037
27,322
28,008
29,626
32,712
32,397
31,993
32,672
35,710
35,980
38,574
37,951
37,696
41,310

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 1 0.00 0.00 2.75 1.5 1 1 1 0.00
Dividend Yield (%) 0.00 0.94 0.00 0.00 0.81 0.52 0.34 0.15 0.34 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Apr 2019 BONUS Bonus
1:1
09 Apr 2019 106.25 117.48
29 Sept 2021 DIVIDEND Dividend
₹ 0.50 /share
28 Sept 2021 388.23 450.80
29 Sept 2021 DIVIDEND Dividend
₹ 0.50 /share
28 Sept 2021 388.23 450.80
23 Sept 2022 DIVIDEND Dividend
₹ 1.50 /share
22 Sept 2022 305.65 365.90
23 Sept 2023 DIVIDEND Dividend
₹ 1.00 /share
22 Sept 2023 303.90 464.90
30 Sept 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2023 375.40 472.65
07 Aug 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
07 Aug 2024 392.05 354.05
24 Sept 2024 DIVIDEND Dividend
₹ 1.00 /share
23 Sept 2024 303.75 389.80
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 383.20 382.80
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 395.10 362.65
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 661.10 624.05
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 569.15 579.25
28 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Jul 2025 519.45 516.25
19 Sept 2025 DIVIDEND Dividend
₹ 1.00 /share
19 Sept 2025 579.25 426.85
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 430.10 494.60
17 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 Oct 2025 468.80 479.35
16 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 Jan 2026 396.10 393.85
08 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 May 2026 322.00 339.90
20 Jul 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Jul 2026 343.15 373.95

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call Transcript4 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome10 days ago
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Jul 20, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 20, 2026
Compliances- Statement Of Deviation & VariationJul 20, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJul 20, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 20, 2026
Results-Financial Results For June 30 2026Jul 20, 2026
Board Meeting Outcome for Outcome Of The Board MeetingJul 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 16, 2026
Board Meeting Intimation for Consideration Of Financial ResultsJul 14, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2026
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Jun 26, 2026
Closure of Trading WindowJun 24, 2026
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015Jun 23, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 15, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 10, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 08, 2026
Compliances-Statement Of Deviation & VariationMay 08, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 08, 2026
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 08, 2026
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 08, 2026
Results- Financial Results For 31/03/2026May 08, 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 08Th May 2026May 08, 2026
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 07, 2026
Board Meeting Intimation for Consideration Of Financial ResultsMay 02, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Closure of Trading WindowMar 24, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 20, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 20, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 19, 2026
Board Meeting Outcome for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Warrants Into Equity SharesMar 18, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 17, 2026
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 17, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Mar 16, 2026
Board Meeting Intimation for Consideration And Approval Of Allotment Of Equity Shares Upon The Exercise Of Options For The Conversion Of Convertible WarrantsMar 13, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportFeb 20, 2026
Announcement Under Regulation 30 (LODR)- UpdatesFeb 02, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 20, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJan 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 18, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 16, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportJan 16, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 16, 2026
Results-Financial Results For December 31 2025Jan 16, 2026
Board Meeting Outcome for Outcome Of The Board MeetingJan 16, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.03%
0
0.00%
0.00%
HDFC Pharma And Healthcare Fund Direct-Growth
0.77%
0
0.00%
0.04%

Technical Indicators

RSI(14)
Neutral
46.81
ATR(14)
Less Volatile
16.31
STOCH(9,6)
Oversold
10.94
STOCH RSI(14)
Oversold
11.13
MACD(12,26)
Bearish
-5.11
ADX(14)
Weak Trend
20.61
UO(9)
Bearish
34.02
ROC(12)
Downtrend And Accelerating
-5.78
WillR(14)
Oversold
-82.52